AEVI-007
AEVI-007-MM-101
Phase 1 small_molecule completed
Quick answer
AEVI-007 for Multiple Myeloma is a Phase 1 program (small_molecule) at Avalo Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Avalo Therapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed